Ireecox MR Tablet is a combination medication containing Etoricoxib 60 mg and Thiocolchicoside 4 mg, formulated for the management of musculoskeletal pain and inflammation. Etoricoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, provides effective anti-inflammatory and analgesic effects by selectively blocking the COX-2 enzyme involved in prostaglandin synthesis, thereby reducing pain and inflammation with a lower risk of gastrointestinal side effects compared to non-selective NSAIDs. Thiocolchicoside, a muscle relaxant with anti-inflammatory properties, acts as a competitive antagonist of GABA and glycine receptors, alleviating muscle spasms and improving mobility. The combination is particularly beneficial in conditions such as acute musculoskeletal disorders, low back pain, osteoarthritis, and inflammatory rheumatic diseases where both pain relief and muscle relaxation are required. Ireecox MR Tablet offers sustained release, ensuring prolonged therapeutic action and improved patient compliance. It is recommended to be taken orally as prescribed by a healthcare professional. Caution is advised in patients with cardiovascular risk factors, gastrointestinal disorders, hepatic or renal impairment, and hypersensitivity to either component. Regular monitoring and adherence to prescribed dosage are essential to minimize adverse effects and optimize therapeutic outcomes.